Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Platelet ultrastructure may serve as disease biomarkers; leaves open prospective validation before clinical adoption in neurodegeneration.
Platelets are evinced as a systemic tool in a variety of disorders, including neurodegenerative diseases. Evidence suggests that variations in the ultrastructure and morphology of platelets and related organelles are involved in the pathophysiology of diabetes, cancer, HIV/AIDS, cardiovascular and neurological diseases. Due to structural alterations of platelets in many diseases, it is informative to discuss the ultrastructural and morphological discrepancies of platelets in contemporary medical research. The present review reveals the usefulness of ultrastructural study in better understanding of the disease patterns and may help to improve the treatment regimes.
No takes yet. Share an insight, caveat, or question.
Shrivastava et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: